At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures
In Brief
A Phase 4 clinical trial evaluating sertraline, CBT-ip, and 2 other interventions for Convulsion, Non-Epileptic and 4 related conditions. Completed, enrolled 38 participants across 3 sites.
Detailed Summary
The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.
Study Details
Timeline
Interventions
flexible dose sertraline
cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: 12 individual 1 hour therapy sessions
flexible dose sertraline and cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: flexible dose sertraline and 12, individual 1 hour therapy sessions
community care, treatment as usual: routine follow up with existing providers